๐งฌ Biotech + Palo Alto, CA
Biotech Venture Capital Firms in Palo Alto, CA
Discover 4 venture capital firms investing in Biotech and headquartered in Palo Alto, CA. This directory highlights investors with active biotech portfolios and a local presence in Palo Alto, CA, helping founders identify the right capital partners for their next raise. Browse firm profiles, compare check sizes and stage focus, and find investors who understand both the biotech landscape and the Palo Alto, CA startup ecosystem.
4 firms
Frequently Asked Questions
What are the best Biotech VC firms in Palo Alto, CA?
Palo Alto, CA is home to 4+ venture capital firms that specialize in Biotech. The top firms combine deep Biotech expertise with local Palo Alto, CA networks, deal flow, and industry connections.
How do I find a Biotech investor in Palo Alto, CA?
Start by reviewing the 4 Biotech-focused VCs based in Palo Alto, CA ranked on this page. Evaluate each firm's stage focus, check size, and portfolio to find the best fit for your startup's needs.
Is Palo Alto, CA a good place to raise Biotech funding?
Palo Alto, CA has an active Biotech investment community with firms specializing in this sector. Local investors bring valuable industry connections and ecosystem advantages specific to the Palo Alto, CA market.
Innovation Endeavors
Palo Alto, CAFounded by Eric Schmidt; invests in sensors, ML, and robotics.
Playground Global
Palo Alto, CADeep technology venture fund investing in AI, robotics, and synthetic biology startups with transformative potential.
S32 (formerly Section 32)
Palo Alto, CAS32, originally named Section 32, is a Palo Alto venture capital firm founded by Bill Maris, who started GV (Google Ventures) and ran it as CEO. S32 invests mainly at Series A and Series B in AI, computational biology, infrastructure, cybersecurity and enterprise software, manages more than $3 billion, and held a $413.5 million first close on its sixth fund in September 2025.
Venrock
Palo Alto, CAVenture capital firm with roots in the Rockefeller family, investing in technology and healthcare companies for over 50 years.